tiprankstipranks
Chromocell Therapeutics Corp (CHRO)
NYSE MKT:CHRO
US Market
Holding CHRO?
Track your performance easily

Chromocell Therapeutics Corp (CHRO) Income Statement

17 Followers

Chromocell Therapeutics Corp Income Statement

Last quarter (Q ), Chromocell Therapeutics Corp's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Chromocell Therapeutics Corp's net income was $-1.69M. See Chromocell Therapeutics Corp’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22
Total Revenue
---
Cost of Revenue
---
Gross Profit
---
Operating Expense
$ 5.88M$ 6.86M$ 2.32M
Operating Income
$ -5.88M$ -6.86M$ -2.32M
Net Non Operating Interest Income Expense
$ -306.19K$ 518.51K$ -140.43K
Other Income Expense
$ -396.22K--
Pretax Income
$ -5.84M$ -7.38M$ -2.46M
Tax Provision
---
Earnings From Equity Interest Net Of Tax
---
Net Income Common Stockholders
$ -5.84M$ -7.38M$ -2.46M
Basic EPS
$ -1.02$ -5.78$ -0.63
Diluted EPS
$ -1.02$ -5.78$ -0.63
Basic Average Shares
$ 29.44M$ 1.28M$ 3.92M
Diluted Average Shares
$ 29.44M$ 1.28M$ 3.92M
Dividend Per Share
---
Total Operating Income As Reported
---
Reported Normalized Basic E P S
---
Reported Normalized Diluted E P S
---
Rent Expense Supplemental
---
Total Expenses
$ 5.88M$ 6.86M$ 2.32M
Net Income From Continuing And Discontinued Operation
$ -5.84M$ -7.38M$ -2.46M
Normalized Income
$ -3.43M$ -5.83M-
Interest Expense
---
EBIT
$ -3.47M$ -6.86M-
EBITDA
$ -3.46M$ -6.67M-
Currency in USD

Chromocell Therapeutics Corp Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis